Differences

This shows you the differences between two versions of the page.

--- endocrine:sglt2:sotagliflozin [2026/02/13 00:09] – created andrew2393cns
+++ endocrine:sglt2:sotagliflozin [2026/02/13 00:09] (current) – [Sotagliflozin vs Other SGLT2 Inhibitors] andrew2393cns
@@ Line 107: / Line 107: @@
 [[endocrine:sglt2:dapagliflozin|Dapagliflozin]] and [[endocrine:sglt2:empagliflozin|Empagliflozin]]:
-• Pure SGLT2 inhibitors
+  * • Pure SGLT2 inhibitors
-• No intestinal SGLT1 inhibition
+  * • No intestinal SGLT1 inhibition
 Sotagliflozin:
-• Dual SGLT1 + SGLT2 inhibition
+  * • Dual SGLT1 + SGLT2 inhibition
-• Greater postprandial glucose reduction
+  * • Greater postprandial glucose reduction
-• More GI side effects
+  * • More GI side effects
 All provide:
-• Heart failure benefit
+  * • Heart failure benefit
-• Renal protection
+  * • Renal protection
 --------------------------------------------------------------------